Skip to main content
Top
Published in: Clinical Rheumatology 12/2008

01-12-2008 | Original Article

Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet’s disease

Authors: Seyithan Taysi, Refik Ali Sari, Hakan Dursun, Adnan Yilmaz, Mustafa Keles, Kerim Cayir, Mehmet Akyuz, Abdullah Uyanik, Adem Guvenc

Published in: Clinical Rheumatology | Issue 12/2008

Login to get access

Abstract

Behcet’s disease (BD) is a chronic, progressive disorder that affects many systems of the body including the eye. The aim of this study was to examine the effects of nitric oxide synthase activity (NOS), nitric oxide \(\left( {{\text{NO}}^ \bullet } \right)\), and homocysteine (Hcy) levels in patients with active BD. Included in this study were 18 male BD patients and 16 male healthy volunteers as controls. Erythrocyte NOS activity, \(\left( {{\text{NO}}^ \bullet } \right)\), erythrocyte sedimentation rate, serum C-reactive protein, and plasma Hcy values in the patients with BD were significantly higher than those of the control group. Our results show that these parameters play a major role in the inflammatory reactions observed in BD.
Literature
1.
go back to reference Behcet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157 Behcet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157
2.
go back to reference Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA (2007) Oxidant/antioxidant status in men with Behcet’s disease. Clin Rheumatol 26:418–422PubMedCrossRef Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA (2007) Oxidant/antioxidant status in men with Behcet’s disease. Clin Rheumatol 26:418–422PubMedCrossRef
3.
go back to reference Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in patients with Behcet’s disease. Ann Clin Lab Sci 32:377–382PubMed Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in patients with Behcet’s disease. Ann Clin Lab Sci 32:377–382PubMed
4.
go back to reference Watanabe K, Ohashi Y (1984) Natural killer cell activity in patients with Behcet’s disease. Am J Ophthalmol 98:813–814PubMed Watanabe K, Ohashi Y (1984) Natural killer cell activity in patients with Behcet’s disease. Am J Ophthalmol 98:813–814PubMed
5.
6.
go back to reference Nussenblatt RBWS, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis, pp 334–353 Nussenblatt RBWS, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis, pp 334–353
7.
go back to reference El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behcet’s disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies? Rheumatol Int 21:176–181PubMedCrossRef El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behcet’s disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies? Rheumatol Int 21:176–181PubMedCrossRef
8.
go back to reference Aktan B, Taysi S, Gumustekin K, Bakan N, Sutbeyaz Y (2003) Evaluation of oxidative stress in erythrocytes of guinea pigs with experimental otitis media and effusion. Ann Clin Lab Sci 33:232–236PubMed Aktan B, Taysi S, Gumustekin K, Bakan N, Sutbeyaz Y (2003) Evaluation of oxidative stress in erythrocytes of guinea pigs with experimental otitis media and effusion. Ann Clin Lab Sci 33:232–236PubMed
9.
go back to reference Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296PubMedCrossRef Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296PubMedCrossRef
10.
go back to reference Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef
11.
go back to reference Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221–227PubMedCrossRef Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221–227PubMedCrossRef
12.
go back to reference Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef
13.
go back to reference Ezirmik N, Taysi S, Celik R, Celik G, Alici HA, Turhan H, Cesur M, Keskin D (2008) Oxidant/antioxidant status in pneumatic tourniquet-induced ischemia-reperfusion in meniscal patients undergoing arthroscopy. Asian J Chem 20:1950–1956 Ezirmik N, Taysi S, Celik R, Celik G, Alici HA, Turhan H, Cesur M, Keskin D (2008) Oxidant/antioxidant status in pneumatic tourniquet-induced ischemia-reperfusion in meniscal patients undergoing arthroscopy. Asian J Chem 20:1950–1956
14.
go back to reference Maeda H, Akaike T (1998) Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 63:854–865 Maeda H, Akaike T (1998) Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 63:854–865
15.
go back to reference Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, Gumus M (2002) Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 32:162–166PubMedCrossRef Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, Gumus M (2002) Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 32:162–166PubMedCrossRef
16.
go back to reference Yildiz M, Taysi S, Umudum Z (2008) Nitric oxide synthase activity in erythrocyte of the rabbits which implanted composite resin filling materials into connective tissue. Asian J Chem 20:3902–3906 Yildiz M, Taysi S, Umudum Z (2008) Nitric oxide synthase activity in erythrocyte of the rabbits which implanted composite resin filling materials into connective tissue. Asian J Chem 20:3902–3906
17.
go back to reference Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, Kritikos H, Boumpas DT, Goulielmos GN (2007) Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus 16(11):867–874PubMedCrossRef Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, Kritikos H, Boumpas DT, Goulielmos GN (2007) Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus 16(11):867–874PubMedCrossRef
18.
go back to reference Rasmussen K, Moller J (2000) Total homocysteine measurement in clinical practice. Ann Clin Biochem 37:627–648PubMedCrossRef Rasmussen K, Moller J (2000) Total homocysteine measurement in clinical practice. Ann Clin Biochem 37:627–648PubMedCrossRef
19.
go back to reference Undas A, Brozek J, Szczeklik A (2005) Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 94:907–915PubMed Undas A, Brozek J, Szczeklik A (2005) Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 94:907–915PubMed
20.
go back to reference Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behcet’s disease. Clin Chem Lab Med 45:73–77PubMedCrossRef Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behcet’s disease. Clin Chem Lab Med 45:73–77PubMedCrossRef
21.
go back to reference van Guldener C, Stehouwer CD (2000) Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26:281–289PubMedCrossRef van Guldener C, Stehouwer CD (2000) Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26:281–289PubMedCrossRef
22.
go back to reference Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6:27–36PubMedCrossRef Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6:27–36PubMedCrossRef
23.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
24.
go back to reference Durak I, Ozturk HS, Elgun S, Cimen MY, Yalcin S (2001) Erythrocyte nitric oxide metabolism in patients with chronic renal failure. Clin Nephrol 55:460–464PubMed Durak I, Ozturk HS, Elgun S, Cimen MY, Yalcin S (2001) Erythrocyte nitric oxide metabolism in patients with chronic renal failure. Clin Nephrol 55:460–464PubMed
25.
go back to reference Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41:892–896PubMed Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41:892–896PubMed
26.
go back to reference Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129PubMedCrossRef Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129PubMedCrossRef
27.
go back to reference Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet’s disease. Tohoku J Exp Med 176:239–248PubMedCrossRef Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet’s disease. Tohoku J Exp Med 176:239–248PubMedCrossRef
28.
go back to reference Demirbag R, Yilmaz R, Guzel S, Celik H, Kocyigit A, Ozcan E (2006) Effects of treadmill exercise test on oxidative/antioxidative parameters and DNA damage. Anadolu Kardiyol Derg 6:135–140PubMed Demirbag R, Yilmaz R, Guzel S, Celik H, Kocyigit A, Ozcan E (2006) Effects of treadmill exercise test on oxidative/antioxidative parameters and DNA damage. Anadolu Kardiyol Derg 6:135–140PubMed
29.
go back to reference Mangoni AA, Jackson SH (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556–565PubMedCrossRef Mangoni AA, Jackson SH (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556–565PubMedCrossRef
30.
go back to reference Alvarez-Maqueda M, El Bekay R, Monteseirin J, Alba G, Chacon P, Vega A, Santa Maria C, Tejedo JR, Martin-Nieto J, Bedoya FJ, Pintado E, Sobrino F (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229–238PubMedCrossRef Alvarez-Maqueda M, El Bekay R, Monteseirin J, Alba G, Chacon P, Vega A, Santa Maria C, Tejedo JR, Martin-Nieto J, Bedoya FJ, Pintado E, Sobrino F (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229–238PubMedCrossRef
31.
go back to reference Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049–1057PubMedCrossRef Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049–1057PubMedCrossRef
33.
go back to reference Wu LL, Wu JT (2002) Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21–28PubMedCrossRef Wu LL, Wu JT (2002) Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21–28PubMedCrossRef
34.
go back to reference Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535–541PubMedCrossRef Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535–541PubMedCrossRef
35.
go back to reference Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, El Matri L, Mebazaa A, Kaabachi N (2004) Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet’s disease. Clin Chem Lab Med 42:1417–1423PubMedCrossRef Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, El Matri L, Mebazaa A, Kaabachi N (2004) Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet’s disease. Clin Chem Lab Med 42:1417–1423PubMedCrossRef
36.
go back to reference Calikoglu E, Oztas M, Sengul N, Adam B, Gurer MA (2002) Serum homocysteine level in Behcet’s disease. Haematologia (Budap) 32:219–224CrossRef Calikoglu E, Oztas M, Sengul N, Adam B, Gurer MA (2002) Serum homocysteine level in Behcet’s disease. Haematologia (Budap) 32:219–224CrossRef
37.
go back to reference Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B, Erman M, Celik I (2001) Interactions of nitric oxide and superoxide dismutase in Behcet’s disease. Clin Exp Rheumatol 19:S25–S29PubMed Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B, Erman M, Celik I (2001) Interactions of nitric oxide and superoxide dismutase in Behcet’s disease. Clin Exp Rheumatol 19:S25–S29PubMed
38.
go back to reference Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet’s disease. Ann Acad Med Singapore 33:596–599PubMed Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet’s disease. Ann Acad Med Singapore 33:596–599PubMed
39.
go back to reference Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoc M (1999) Decreased nitric oxide production in patients with Behcet’s disease. Dermatol 198:33–36CrossRef Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoc M (1999) Decreased nitric oxide production in patients with Behcet’s disease. Dermatol 198:33–36CrossRef
40.
go back to reference Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S, Mercan E (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 153:526–530PubMedCrossRef Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S, Mercan E (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 153:526–530PubMedCrossRef
41.
go back to reference Aktan B, Taysi S, Gumustekin K, Ucuncu H, Memisogullari R, Save K, Bakan N (2003) Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. Pol J Pharmacol 55:1105–1110PubMed Aktan B, Taysi S, Gumustekin K, Ucuncu H, Memisogullari R, Save K, Bakan N (2003) Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. Pol J Pharmacol 55:1105–1110PubMed
42.
go back to reference Bakan N, Taysi S, Yilmaz O, Bakan E, Kuskay S, Uzun N, Gundogdu M (2003) Glutathione peroxidase, glutathione reductase, Cu–Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 338:143–149PubMedCrossRef Bakan N, Taysi S, Yilmaz O, Bakan E, Kuskay S, Uzun N, Gundogdu M (2003) Glutathione peroxidase, glutathione reductase, Cu–Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 338:143–149PubMedCrossRef
Metadata
Title
Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet’s disease
Authors
Seyithan Taysi
Refik Ali Sari
Hakan Dursun
Adnan Yilmaz
Mustafa Keles
Kerim Cayir
Mehmet Akyuz
Abdullah Uyanik
Adem Guvenc
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0963-4

Other articles of this Issue 12/2008

Clinical Rheumatology 12/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.